Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.

Abraham, Michal; Wald, Hanna; Vaizel-Ohayon, Dalit; Grabovsky, Valentin; Oren, Zohar; Karni, Arnon; Weiss, Lola; Galun, Eithan; Peled, Amnon; Eizenberg, Orly

Abraham, Michal; Wald, Hanna; Vaizel-Ohayon, Dalit; Grabovsky, Valentin; Oren, Zohar; Karni, Arnon; Weiss, Lola; Galun, Eithan; Peled, Amnon; Eizenberg, Orly.

Afiliación

Abraham M; Biokine Therapeutics Ltd, Ness Ziona, Israel.
Wald H; Biokine Therapeutics Ltd, Ness Ziona, Israel.
Vaizel-Ohayon D; Biokine Therapeutics Ltd, Ness Ziona, Israel.
Grabovsky V; Biokine Therapeutics Ltd, Ness Ziona, Israel.
Oren Z; Biokine Therapeutics Ltd, Ness Ziona, Israel.
Karni A; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Weiss L; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Galun E; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel.
Peled A; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel.
Eizenberg O; Biokine Therapeutics Ltd, Ness Ziona, Israel.

Front Immunol ; 8: 1432, 2017.

Article en En | MEDLINE | ID: mdl-29218043

Palabras clave

autoimmunity; chemokines; inflammation; peptibodies; phage display

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2017 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google